Growth Metrics

BeOne Medicines (ONC) Construction in Progress (2016 - 2025)

BeOne Medicines (ONC) has disclosed Construction in Progress for 9 consecutive years, with $127.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Construction in Progress fell 80.56% to $127.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $127.2 million, a 80.56% decrease, with the full-year FY2025 number at $127.2 million, down 80.56% from a year prior.
  • Construction in Progress was $127.2 million for Q4 2025 at BeOne Medicines, down from $129.1 million in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $863.4 million in Q2 2024 to a low of $70.8 million in Q1 2021.
  • A 5-year average of $394.4 million and a median of $353.7 million in 2025 define the central range for Construction in Progress.
  • Peak YoY movement for Construction in Progress: skyrocketed 184.02% in 2023, then plummeted 80.56% in 2025.
  • BeOne Medicines' Construction in Progress stood at $186.8 million in 2021, then skyrocketed by 57.15% to $293.6 million in 2022, then surged by 152.23% to $740.6 million in 2023, then dropped by 11.69% to $654.0 million in 2024, then tumbled by 80.56% to $127.2 million in 2025.
  • Per Business Quant, the three most recent readings for ONC's Construction in Progress are $127.2 million (Q4 2025), $129.1 million (Q3 2025), and $353.7 million (Q2 2025).